Portfolio news Archives - Page 11 of 13

A year in review: 2020

Looking back at 2020: We only turned 4 this year, and have had a great journey so far, but we still have so much more to…

clement16.12.2020

Alloy Therapeutics becomes BaseLaunchs Domain Partner

Portfolio news

Alloy Therapeutics becomes BaseLaunch’s first dedicated antibody discovery Domain Partner

“We are excited to partner with the BaseLaunch team and support their continued success developing a vibrant hub for biotechnology innovation in the Basel Area,”…

clement24.11.2020

Portfolio news

Synendos Therapeutics raises $21 Million

We are very proud to announce that Synendos Therapeutics has raised a USD 21M series A co-led by Kurma Partners and Sunstone Life Science Ventures.…

clement11.11.2020

It is great to see how vibrant the biotech scene in Switzerland has become

Portfolio news

SpiroChem AG, announces their partnership with BaseLaunch

“We are very excited to partner with SpiroChem such that our portfolio companies can gain access to highest quality medical chemistry expertise and support! And…

clement27.10.2020

Portfolio news

Johnson & Johnson Innovation renews its commitment

“We are delighted to announce that Johnson & Johnson Innovation, is continuing its partnership with BaseLaunch to help support cutting-edge early-stage biotechs to achieve financing…

clement29.09.2020

Portfolio news

Pureos Bioventures, announces closing of their first fund, at USD 170 million

“We are extremely pleased with the successful closing of our first fund. This would not have been possible without the trust and support of our…

clement24.09.2020

Portfolio news

Investors see great potential in Polyneuron

Polyneuron Pharmaceuticals, a BaseLaunch portfolio company, has concluded the extension of its Series A financing round. With further investment of 14 million francs, the startup has…

clement17.09.2020

Portfolio news

TOLREMO Therapeutics receives additional CHF 4.7 million financing

This second closing of CHF 4.7M is led by BioMedPartners AG and Altos Ventures AG, who are joining the previous investors Redalpine Venture Partners AG,…

clement19.08.2020

Portfolio news

Alentis Therapeutics appoints Dr. Roberto Iacone

Dr. Iacone is a physician-scientist with more than 15 years of experience in the life science industry. Before Alentis he was Global Head of Rare…

clement19.08.2020

Portfolio news

Versameb closes CHF 6 million seed round

Versameb also welcomes Dr. Klaas P. Zuideveld as Chief Development Officer. Prior to Versameb he was Vice President of Partnerships at Caris Life Sciences, and…

clement19.08.2020

Portfolio news

A year in review: 2020

Alloy Therapeutics becomes BaseLaunch’s first dedicated antibody discovery Domain Partner

Synendos Therapeutics raises $21 Million

SpiroChem AG, announces their partnership with BaseLaunch

Johnson & Johnson Innovation renews its commitment

Pureos Bioventures, announces closing of their first fund, at USD 170 million

Investors see great potential in Polyneuron

TOLREMO Therapeutics receives additional CHF 4.7 million financing

Alentis Therapeutics appoints Dr. Roberto Iacone

Versameb closes CHF 6 million seed round

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us